Natural Product: NPC159178

Natural Product IDNPC159178
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(Z)-N-Benzyltetracos-15-Enamide
IUPAC Name (Z)-N-benzyltetracos-15-enamide
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2413163
PubChem CID 73347575
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0000331] Fatty amides
          • [CHEMONTID:0001096] N-acyl amines

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LQJKLTWHJMDOQD-KTKRTIGZSA-N
Standard InCHI InChI=1S/C31H53NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-28-31(33)32-29-30-26-23-22-24-27-30/h9-10,22-24,26-27H,2-8,11-21,25,28-29H2,1H3,(H,32,33)/b10-9-
SMILES CCCCCCCC/C=CCCCCCCCCCCCCCC(=NCc1ccccc1)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   455.41 Volume:   542.78
?
Van der Waals volume.
Dense:   0.839 LogP:   9.881
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.901
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -8.073
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   23.0 Rigid Bonds:   8.0
TPSA:   32.59
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   1.0 Rings:   1.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.076 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.516 Fsp3:   0.71
MCE-18:   5.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.672 Fluc inhibitor:   0.217
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.002
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.363
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.165 Promiscuous compounds:   0.065

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.069 MDCK Permeability:   -4.828
Pgp-inhibitor:   0.309 Pgp-substrate:   0.0
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.137
20% Bioavailability (F20%):   0.817 30% Bioavailability (F30%):   0.985
50% Bioavailability (F50%):   0.577

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.007 MRP1:   0.977
Plasma Protein Binding (PPB):   99.464% Volume Distribution (VD):   0.51
Fu: 0.185%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.071
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.065
BSEP inhibitor:   0.999

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   1.0
CYP2C19-inhibitor:   0.001 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   0.869
CYP2D6-inhibitor:   1.0 CYP2D6-substrate:   0.002
CYP3A4-inhibitor:   0.078 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.001 CYP2C8-inhibitor:   1.0
HLM stability:   0.002
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.69 Half-life (T1/2):  1.021

ADMET: Toxicity

hERG Blockers:  0.479 hERG Blockers (10um):  0.855
Human Hepatotoxicity (H-HT):  0.867 Drug-induced Liver Injury (DILI):  0.149
AMES Toxicity:  0.254 Rat Oral Acute Toxicity:  0.049
Maximum Recommended Daily Dose:  0.659 Skin Sensitization:  1.0
Carcinogencity:  0.486 Eye Corrosion:  0.022
Eye Irritation:  0.935 Respiratory Toxicity:  0.959
Drug-induced Neurotoxicity:  0.027 Ototoxicity:  0.11
Hematotoxicity:  0.037 Drug-induced Nephrotoxicity:  0.724
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.006
A549 Cytotoxicity:  0.262 Hek293 Cytotoxicity:  0.225
BCF:   0.712
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.333
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.716
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.095
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[12932133]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[23891163]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[24972328]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[33320645]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1418 Individual protein Anandamide amidohydrolase Homo sapiens IC50 > 500000.0 nM PMID[19124664]
NPT1418 Individual protein Anandamide amidohydrolase Homo sapiens Inhibition < 10.0 % PMID[20643902]
NPT1418 Individual protein Anandamide amidohydrolase Homo sapiens Inhibition = 49.2 % PMID[16933872]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC159178 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC74936
0.9268 High Similarity NPC209764
0.8571 High Similarity NPC483616
0.8421 Intermediate Similarity NPC471307
0.8421 Intermediate Similarity NPC78041
0.8421 Intermediate Similarity NPC141139
0.8372 Intermediate Similarity NPC121872
0.75 Intermediate Similarity NPC483617
0.7059 Intermediate Similarity NPC202613
0.7 Intermediate Similarity NPC53596
0.6604 Remote Similarity NPC289330
0.6111 Remote Similarity NPC483619
0.6111 Remote Similarity NPC483621
0.6078 Remote Similarity NPC471311
0.6 Remote Similarity NPC160120
0.6 Remote Similarity NPC6854
0.58 Remote Similarity NPC471308
0.58 Remote Similarity NPC483618
0.58 Remote Similarity NPC17388
0.5741 Remote Similarity NPC471313
0.5536 Remote Similarity NPC483622
0.5472 Remote Similarity NPC483623
0.5357 Remote Similarity NPC483620
0.5294 Remote Similarity NPC74427

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC159178 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5918 Remote Similarity NPD6690 Phase 2
0.55 Remote Similarity NPD7153 Discontinued
0.5111 Remote Similarity NPD187 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data